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The extent of infarct injury is a key determinant of structural and
functional remodeling following myocardial infarction (MI). Infarct
volume in experimental models of MI can be determined accurately
by in vivo magnetic resonance imaging (MRI), but this is costly and
not widely available. Experimental studies therefore commonly assess
injury by histological analysis of sections sampled from the infarcted
heart, an approach that is labor intensive, can be subjective, and does
not fully assess the extent of injury. The present study aimed to assess
the suitability of optical projection tomography (OPT) for identifica-
tion of injured myocardium and for accurate and efficient assessment
of infarct volume. Intact, perfusion-fixed, optically cleared hearts,
collected from mice 7 days after induction of MI by coronary artery
occlusion, were scanned by a tomograph for autofluorescence emis-
sion after UV excitation, generating 400 transaxial sections for
reconstruction. Differential autofluorescence permitted discrimination
between viable and injured myocardium and highlighted the hetero-
geneity within the infarct zone. Two-dimensional infarct areas derived
from OPT imaging and Masson’s trichrome staining of slices from the
same heart were highly correlated (r2  0.99, P  0.0001). Infarct
volume derived from reconstructed OPT sections correlated with
volume derived from in vivo late gadolinium enhancement MRI (r2
0.7608, P  0.005). Tissue processing for OPT did not compromise
subsequent immunohistochemical detection of endothelial cell and
inflammatory cell markers. OPT is thus a nondestructive, efficient,
and accurate approach for routine in vitro assessment of murine
myocardial infarct volume.
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NEW & NOTEWORTHY
Optical projection tomography permits rapid high-resolution
imaging of intact murine heart in vitro and identification of
tissue heterogeneity within individual optical slices of postmyo-
cardial infarction hearts. Infarct volume derived from 400
slices correlates with in vivo magnetic resonance imaging and
avoids the need for histological staining of multiple physical
sections.
MURINE MODELS ARE WIDELY USED to study injury, repair, and
remodeling of the heart following myocardial infarction (MI),
as well as in the development of novel therapies to prevent
progression to heart failure (9). The extent of infarct injury in
the immediate postischemic period and after infarct healing is
a critical determinant of long-term structural and functional
outcome. Accurate determination of infarct size is thus vital in
interpretation of these outcomes. The current gold standard for
infarct measurement in clinical (5) and experimental studies
(31) is magnetic resonance imaging (MRI) using a contrast
agent such as gadolinium (Gd) to enhance the image of the
infarcted area [late Gd enhancement (LGE)]. This permits
three-dimensional (3D) assessment of infarct volume. How-
ever, as LGE-MRI requires expensive specialist equipment,
assessment of experimental infarct injury more typically relies
on 2D histological assessment in a single section or multiple
sections collected from the infarct area. Histological methods
are time consuming, fail to provide information on infarct
volume, and are less sensitive than 3D assessment for detection
of changes in the extent of injury during healing (3). The
increased error arising from dependence on histological anal-
ysis in a limited range of sections can result in a need for
increased groups sizes to adequately power studies for statis-
tical analysis, and consequently higher animal use.
Optical projection tomography (OPT) was originally devel-
oped for enhanced imaging of whole mount mouse embryos
and can be applied to image biological samples up to a depth
of 15 mm with high resolution (22). Briefly, once optically
cleared, the sample is suspended in an index-matching liquid to
reduce light scattering. As the sample moves 360° around the
scanner, 400 images are collected and virtual sections are then
reconstructed to acquire a detailed 3D image (15, 21a). The
samples are illuminated by visible light for transmission im-
aging to distinguish anatomical structures. Alternatively emis-
sion imaging can record light emitted following excitation at
varied wavelengths, detecting either endogenous fluorescence
or fluorescence emitted by fluorophores placed within the
tissue e.g., associated with specific antibodies. Anatomical
structure can be derived from both due to distinct differences in
light transmission and autofluorescence between tissues. Since
the launch of this technique, OPT has been applied in devel-
Address for reprint requests and other correspondence: G. A. Gray, BHF/
Univ. Centre for Cardiovascular Science, Univ. of Edinburgh, Queens Medical
Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK
(e-mail: gillian.gray@ed.ac.uk).
Am J Physiol Heart Circ Physiol 309: H702–H710, 2015.
First published June 12, 2015; doi:10.1152/ajpheart.00233.2015.Innovative Methodology
Licensed under Creative Commons Attribution CC-BY 3.0: © the American Physiological Society. ISSN 0363-6135. http://www.ajpheart.orgH702
Downloaded from journals.physiology.org/journal/ajpheart (146.066.043.047) on June 11, 2020.
opmental biology (10, 13, 23), for gene-expression analysis
(25), to localize labeled cells within a tissue (30), and to screen
normal and abnormal anatomy (12, 24). Kirkby et al. (15)
recently described an elegant application of OPT to provide 3D
quantification of murine neointimal and atherosclerotic lesions.
The components and fluorescence characteristics of tissue in
the healing MI are distinct from those of healthy myocardium.
The present study therefore aimed to investigate the potential
of OPT for identification and quantification of the extent of
infarct injury during the infarct healing phase 7 days after
induction of MI by left coronary artery ligation. The outcomes
were compared with those from in vivo LGE-MRI and 2D
histological assessment in hearts from the same mice. As tissue
processing is required to obtain OPT images, hearts collected
following OPT were also sectioned to test their suitability for
subsequent immunohistochemical studies.
MATERIALS AND METHODS
Animals. We obtained 10 male C57BL/6 mice, age 12–14 wk, from
Harlan UK. All animal experiments were performed in accordance
with the Animals (Scientific Procedures) Act (UK), 1986 and ap-
proved by the University of Edinburgh Preclinical Ethical Review
Committee. All mice underwent the protocol described in Fig. 1.
Induction of MI. After administration of analgesic (buprenorphine,
1 mg/kg sc), each mouse’s chest was anesthetized with isoflurane
(2%), ventilated (stroke volume 240 l, 120 breaths/min), and opened
at the left third intercostal space to expose the heart. The pericardium
was partially removed, and a 6-0 prolene suture was placed under the
left anterior coronary artery and tied. The distance between the
ligature position and the apex was varied to achieve a variety of
infarct sizes for analysis. Successful ligation was indicated by blanch
of the ventricle. After closing the chest, we injected 1.0–1.5 ml
prewarmed 0.9% saline sc into the left flank to aid recovery, and mice
were allowed to recover overnight on a heated pad.
Cardiac troponin I. Twenty-four hours after induction of ischemia,
30 l blood was collected by tail nick into a tube containing 30 l
3.2% sodium citrate for determination of cardiac troponin I (cTnI) by
high-sensitivity ELISA (Life Diagnostics), as an index of the extent of
myocardial injury following coronary artery ligation. The limit of detec-
tion for cTnI was 0.156 ng/ml. One mouse had a plasma level of cTnI5
ng/ml and was excluded from the study as a missed ligation.
MRI. Mice were scanned 7 days after induction of MI in a 7T MRI
system (Agilent Technologies) with a quadrature birdcage coil (33
mm inner diameter). We instrumented isoflurane-anesthetized mice to
assess respiration rate and ECG for signal gating; body temperature
was maintained at 37°C by a hot air blower with feedback control.
For LGE-MRI, 0.5 mmol/kg gadoterate meglumine (Gd-DOTA;
Dotarem, Guerbet, France) was administered intraperitoneally. Scout
images were acquired to guarantee correct positioning of consecutive
scans, and flip angle calibration was performed 35–40 min after
Gd-DOTA injection; cardiac-gated short-axis inversion recovery gra-
dient echo images covering the entire left ventricle (8–10 slices) were
acquired with the following parameters: repetition time 410 ms
(depending on heart rate); echo time 1.94 ms; inversion time 350 ms;
acquisition matrix 128  128; field of view 30 mm  30 mm; slice
thickness 1 mm; pulse angle 90°; number of signal averages 4. This
time point was chosen to obtain the best contrast between remote and
infarcted myocardium as described (3).
Following LGE, MR cine-images were acquired for functional
analysis using a cardiac- and respiratory-gated gradient echo pulse
sequence with the following parameters: repetition time 6 ms; echo
time 1.8 ms; acquisition matrix 192 192; field of view 30 mm 30
mm; number of time frames 16; slice thickness 1 mm; pulse angle 15°;
number of signal averages 2. Images were acquired in the 2-chamber
(1-slice), 4-chamber (1-slice), and short-axis (8–10 slices) orienta-
tions. The entire MRI session lasted 60 min. Ejection fraction,
end-diastolic volume, end-systolic volume, and stroke volume were
assessed, in a blinded manner using CAAS software (Pie Medical,
Maastricht, the Netherlands). The papillary muscles and pericardium
where present after surgery were excluded from analysis for all data
sets.
OPT imaging. Following MRI, hearts were fixed in situ by perfus-
ing anesthetized mice via the abdominal aorta with 10 IU/ml heparin
in 0.9% saline followed by 10% phosphate buffered formalin. The
hearts were postfixed in 10% phosphate buffered formalin overnight
then rehydrated in PBS. Hearts were embedded in 1.5% low-melting-
point agarose (Invitrogen, UK), dehydrated in 100% methanol (twice,
for 24 h each), and optically cleared by immersion in a mixture of 1
part benzyl alcohol (Sigma-Aldrich, UK) to 2 parts benzyl benzoate
(BABB, Acros Organics, UK) for 48 h. Cleared hearts were scanned
in a calibrated Bioptonics 3001 tomograph (Bioptonics, UK). Optical
magnification was determined to provide the smallest voxel size while
allowing the entire heart to be visualized, which resulted in a voxel of
17.053 m3. All hearts were imaged through emission imaging after
UV illumination (470 nm excitation filter with 40 nm band pass;
emission filter: 515 nm long pass; 1,024  1,024 pixel resolution) for
10–15 min per heart to generate 400 projections per scan with a 0.9°
rotation.
Tomographic reconstruction by Hamming-filtered back-projection
was performed using NRecon software (Skyscan, Belgium). The
quality of reconstruction and 3D views were manually verified using
DataViewer software (Skyscan).
Preparation of histological sections after OPT scanning. After
OPT scanning, hearts were returned to 100% methanol to remove
benzyl alcohol benzyl benzoate (twice, for 24 h each) before rehy-
dration. Hearts were then cut on their short axis at the level of the
ligature and embedded in paraffin. Hearts were sliced transversely
from the ligation to the apex with a microtome at 5 m thickness with
an interval of 300 m between each sections, as described (26). We
acquired six to eight sections from the ligation to the apex and
selected four for comparison with OPT optical sections. Sections were
mounted on glass slides and underwent Masson’s trichrome staining
for infarct identification. One heart was damaged during sectioning
and was removed from the study.
3D infarct volume measurement by MRI and OPT. For 3D quantifi-
cation and comparison of infarct size, LGE-MRI image files were first
converted to Digital Imaging and Communications in Medicine
(DICOM) format, the international standard for medical images and
related information. For LGE-MRI, infarct was identified by semiauto-
matic threshold setting with CAAS software (Pie Medical) to allow
quantification of viable and infarcted myocardium (Fig. 2A). For OPT
imaging, 3D volume quantification was performed using Analyze 11
(AnalyzeDirect, Overland Park, KS). In brief, reconstructed tomographic
image files were imported into Analyze, then intensity thresholds were
adjusted manually for one slice to achieve the optimum delineation
between viable and infarcted tissue. A standard region growing algorithm
within Analyze then allowed identification of regions of interest (ROIs)
for infarct volume within that slice. Areas away from the infarcted
 d7 d0 24h 
Fig. 1. Flowchart of experimental protocol. LGE, late gadolinium enhance-
ment; OPT, optical projection tomography.
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ventricle that had similar pixel intensity e.g., the pericardium, were
manually excluded (see Fig. 2B). This process was repeated at intervals
of 10–20 slices throughout the infarct (260–340 slices), and then ROIs
were propagated automatically for all slices in between the manually
adjusted slices, forming an infarct ROI for the whole left ventricle (LV).
Similarly, LV volume was determined by manually segmenting epicar-
dial and endocardial contours at intervals of every 50 slices (360–450
slices), with automatic propagation of contours for all slices in between.
LV volume was then calculated as the difference between epicardial and
endocardial volumes. The pixel intensity threshold of the infarcted area
was adjusted in both software packages so that only the lesion was
selected. Infarct size was calculated as a proportion of LV volume
(infarct volume/total LV volume  100, LV volume includes viable
myocardium above ligation). All OPT analyses were performed in a
blinded manner and independently of MR images.
2D infarct area quantification by histology and OPT. Histological
sections were scanned (Axio Scan. Z1, Carl Zeiss, Germany). Images
were initially processed by Zen blue 2012 software (Carl Zeiss) and then
saved as a compatible JPG format for subsequent analysis in ImageJ
1.47v for Mac OS X. Histological sections corresponding to OPT optical
sections were identified based on the distance from the ligation, in the
z-axis and on localization with respect to the papillary muscle. Area
measurements in Image J were performed in a blinded manner. Infarct
area in both histological sections and OPT tomographic reconstructions
were traced manually (Fig. 2, C and D). We achieved LV area measure-
ment by tracing the endocardial and epicardial borders. Infarct size was
calculated as sum of infarct areas/sum of LV areas from four histological
sections or OPT reconstructed optical sections and multiplied by 100. All
histological analysis was performed in a blinded manner.
Post-OPT immunohistochemistry. Immunohistochemistry was per-
formed for Mac-2 (total macrophages) and CD31 (endothelial cells) to
test the retention of immunoreactivity in sections following OPT
processing and imaging. In brief, rehydrated paraffin sections were
incubated with primary rat anti-mouse/human Mac-2 antibodies (1:
4,000 dilution overnight; Cedarlane, Ontario, Canada) and rabbit
anti-mouse CD31 antibodies (1:50 dilution overnight; Abcam, UK)
before incubation with biotinylated rabbit anti-rat IgG (1:200 dilution
40 min; Vector Labs, UK) or biotinylated goat anti-rabbit IgG sec-
ondary antibodies (1:200 dilution 40 min; Vector Labs), respectively.
The sections were then treated with avidin and biotinylated horserad-
ish peroxidase macromolecular complex (3 drops/slide 30 min; Vector
Labs) before coloring by 3,3=-diaminobenzidine substrate kit (100
l/slide 3–5 min; Vector Labs).
Statistical analysis. Statistical analysis was performed using Prism
6f for Mac OS X (GraphPad Software). 2D and 3D infarct size
quantification by OPT, histology, and MRI were analyzed by corre-
lation analysis (Pearson correlation coefficient, r2), followed by
Bland-Altman analysis. P  0.05 was considered statistically signif-
icant.
C
A B
D
Fig. 2. 3D (A, B) and 2D (C, D) quantifica-
tion of infarct size acquired by MRI, OPT,
and histology. This figure shows a section
through the same heart viewed by MRI (A),
OPT (B and D), and histology (C). For 3D
infarct volume measurement, in images gen-
erated by T2* weighted LGE-MRI (A), semi-
automatic thresholding permitted separation
of viable myocardium (black) from infarcted
myocardium [white after injection of gado-
linium (Gd) contrast, with yellow contour].
In OPT reconstructions, infarct threshold set-
ting was based on weaker emission from the
infarct scar, highlighted in red (B). For 2D
infarct area measurement, the infarct area is
identified by blue staining in Masson’s
trichrome-stained sections (C). D: the same
section viewed using OPT, in both the infarct
is traced in red. In all images, signal associ-
ated with the pericardium and the fluid within
the pericardial sac (in in vivo MR only) is
manually excluded for analysis.
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RESULTS
Coronary artery ligation induces a range of infarct injury.
All 10 animals undergoing coronary artery ligation surgery
survived until the end of the study. The plasma concentration
of cTnI varied between 33.54 and 91.29 ng/ml in blood
collected 24 h after induction of MI demonstrating a range in
the extent of cardiac injury attained in response to coronary
artery ligation. Troponin I was 5 ng/ml in one mouse, which
was subsequently found to be a sham with no discernable
infarct; the heart from this mouse was removed from subse-
quent analysis.
Fluorescent emission imaging with excitation at 470 nm
is optimal for identification of myocardial injury. To deter-
mine the suitability of OPT for the identification of infarcted
myocardium, 7 day postinfarct hearts were scanned for
visible light transmittance and at two different fluorescent
emission wavelengths (Fig. 3). While scanning in the visible
(white) light channel, the contrast between viable and in-
farcted myocardium was sufficient to allow image recon-
struction. However, emission from collagen or other fibrotic
elements was too bright and widely distributed to permit
threshold setting and analysis (Fig. 3, A and D). In both
fluorescence emission channels, the viable myocardium was
observed to have strong autofluorescence and was clearly
delineated from infarct regions. Better resolution in the
noninfarcted tissue and optimal discrimination between in-
farct and healthy myocardium were achieved following
excitation at 470 nm (Fig. 3, C and F), and fluorescent
emission imaging with excitation at 470 nm was thus ad-
opted for all further investigations.
OPT reconstruction and histological assessment provide
comparable measures of infarct area in 2D sections. 2D
OPT reconstruction provided remarkably similar identifica-
tion of infarct injury to Masson’s trichrome-stained histo-
logical sections subsequently collected at corresponding
levels of the same heart (Fig. 4A). A wide range of infarct
sizes were acquired (Fig. 4B), and significant correlation
was evident between infarct sizes derived from the average
of four histological sections sampled from the infarct and
four optical OPT slices (r2  0.99, P  0.0001, n  8).
Bland-Altman analysis indicated a bias of only 0.046% LV,
and all plots were within the 1.96 SD limits of agreement
(	3.75 to 3.84% LV) (Fig. 4C).
Infarct characteristics and infarct volume data generated by
OPT correlate with LGE-MRI. Noninvasive cardiac LGE-MRI
A B C
D E F
Fig. 3. Optimization of image acquisition for identification and measurement of infarct regions in the mouse heart postmyocardial infarction (MI). In
nontomographic projection images of an infarcted mouse heart, thinning of infarcted area is clearly visible (black arrowheads) when images were obtained using
whether white (visible, A) or fluorescent light (B, 545 nm; C, 470 nm), compared with the darker viable myocardium. In tomographic reconstructions (D–F),
the infarct region (dark, dashed contours) is optimally separated from the brighter viable myocardium, when applying the 470 nm excitation filter (F).
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was performed in mice 7 days after induction of MI and
immediately prior to collection of hearts for OPT imaging.
Four-chamber images were generated from both techniques
(Fig. 5, A and D), and 2D sections collected from both
indicated matching localization and extent of injury (Fig. 5, B
and C). The average infarct volume was 29.3 3.1% LV when
assessed by LGE-MRI and 23.3  3.0% LV when assessed by
OPT (P  0.93, n  9). Correlation analysis shows that the
two methods correlated strongly for infarct volume measure-
ment (R2  0.76, P  0.002, n  9, Fig. 5E). Bland-Altman
analysis indicates no obvious systematic bias in measurements
of infarct volume (6.01% LV, n 9), and all plots were within
the limits of agreement ( 1.96 SD, 	3.19 to 15.21% LV,
Fig. 5F).
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Fig. 4. Comparison of infarct size deter-
mined by OPT and histology in 2D sections.
Short-axis sections from the same heart (A)
are shown from the level of ligation (1) to the
heart apex (8), viewed both as OPT tomo-
graphic reconstructions (bottom panels) and
corresponding Masson’s trichrome-stained
histological sections (top panels). Viable
myocardium is bright (OPT) or red/pink (his-
tology), while infarcted tissue is dark (OPT)
or blue (histology). Correlation (B) and
Bland-Altman analysis (C) were performed
to compare the 2 methods on infarct size
measurement. Sections 3–6 were used for
2D determination of infarct size (highlighted
by red rectangles).
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Infarct volume measured by 3D OPT or LGE-MRI correlates
significantly with left ventricular ejection fraction. Left ventricular
ejection fraction (LVEF) was measured by cine-MRI at the time
of LGE-MRI assessment as an index of systolic function. Infarct
volume derived from OPT was found to correlate highly with
function (R2  0.7684, P  0.0019, Fig. 6A) and to a similar
extent as correlation of infarct volume generated from LGE-MRI
and LVEF (R2  0.7794, P  0.0016, Fig. 6B).
Tissue processing for OPT does not compromise later im-
munohistochemical staining of the healing MI. In hearts pre-
viously subjected to OPT scanning, immunohistochemical
staining using antibodies directed against markers of macro-
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Fig. 5. Comparison of LGE-MRI and 3D OPT for infarct detection and volume assessment. A longitudinal 4-chamber image obtained by cine-MRI (A) was used
to position collection of short-axis sections imaged by LGE-MRI (B, white region indicates infarction while viable myocardium in black) or OPT reconstructions
(C, infarct dark and viable myocardium bright). D: the OPT nontomographic projection of the same heart. Correlation (E) and Bland-Altman analysis (F) were
performed to compare the 2 methods (n  9 mice).
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Fig. 6. Correlation of systolic function with
infarct volume assessed by 3D OPT and
LGE-MRI. Left ventricular ejection fraction
(LVEF) was calculated as an index of sys-
tolic function by cine-MRI. Infarct volume
generated from 3D OPT (A) and LGE-MRI
(B) are both highly correlated with LVEF,
n  9.
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phages (Mac-2) and endothelial cells (CD31) occurred with the
expected intensity and distribution (Fig. 7).
DISCUSSION
This study demonstrates the suitability of OPT as a novel
method for visualization of myocardial injury and for quanti-
fication of infarct volume in the healing murine heart following
MI. Detection of differential tissue fluorescence in multiple
“optical” slices allows discrimination between infarcted and
viable myocardium in the intact heart, permitting 3D recon-
struction and calculation of infarct volume without the need for
physical sectioning (see video in the supplementary file).1 The
resulting data correlate well with output from in vivo assess-
ment by MRI, and the tissue remains suitable for subsequent
immunohistochemistry or histology where required.
Infarct size is a key determinant of structural and functional
outcome following MI. In the clinical setting, acute injury in
patients is assessed by plasma biomarkers, such as troponin
(18), and, where it is available, by MRI or PET, allowing
calculation of infarct volume (27, 32). Advanced in vivo
imaging can also be applied in preclinical studies (6, 17), but
the equipment required is expensive and not widely available.
Most preclinical MI studies depend on histological assessment
of injury in tissue sections samples from the infarct, either
acutely, with triphenyl tetrazolium chloride [TTC, (20)] or
after the infarct scar has developed, with Masson’s trichrome
staining (26). Unless multiple sections are collected throughout
the length of the infarct, these histological approaches give at
best an estimate of infarct injury rather than an actual mea-
surement of infarct volume.
In the present study the inherent autofluorescent character-
istics of the myocardium have been exploited to permit iden-
tification of healthy myocardium and to distinguish it from
damaged infarct tissue that has distinct emission characteris-
tics. The OPT scanning technique permits collection of multi-
ple “optical slices” in different planes. Analysis of individual
optical sections collected in the short axis reveals a close
correlation between areas of infarct identified by fluorescence
emission after excitation at 470 nm with those identified
subsequently in sections from the same hearts by histological
staining with Masson’s trichrome. The precise physical prin-
ciples on which autofluorescence at 470 nm depend are not
clear. Contractile filament proteins and components of cellular
metabolism e.g., reduced forms of NADPH and FAD, are
endogenous fluorophores; the latter may contribute to the
signal arising from cells that had been metabolically active
(21). Emission spectra can also be altered by relative content of
collagen and elastin, also endogenous fluorophores that are
likely to be more prevalent in the infarct tissue visualized here
by OPT (21). The capacity to detect healthy tissue is particu-
larly important in the murine infarcts where the infarct area is
often thinned and delineation of structures within the thinned
area can be challenging. In the present study hearts were1 The online version of this article contains supplemental material.
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Fig. 7. Immunohistochemical staining of heart
sections are not compromised by prior tissue
preparation for OPT scanning. Sections, col-
lected from paraffin-embedded hearts of 7
days postinfarct mice, were immunostained
for detection of macrophages (A, Mac-2) and
endothelial cells (B, CD31). Scale bars are
500 m in left panels and 50 m in right
panels.
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collected at 7 days after induction of MI, when the healing
infarct contains both viable and granulation tissue, in order to
test the potential for OPT to discriminate between them. One of
the key benefits of OPT is the ability to identify this hetero-
geneity and then to use information from hundreds of slices to
reconstruct a complete 3D image of the heart identifying the
full extent of the infarct and allowing calculation of volume
(see video in supplementary file). Generating comparable data
from histological sections would be extremely labor intensive
and time consuming. In comparison, tissue preparation for
OPT is straightforward, and imaging acquisition times are
short, allowing high throughput of hearts. While not included
in the present study, it will be of interest in future to assess the
potential for OPT to discriminate between viable and nonviable
myocardium in the early stages after infarction, compared with
the established TTC method (21), as well as in more advanced
repair when the infarct area is thinned and replaced largely by
scar.
The gold standard for collection of 3D infarct volume is
considered to be MRI, particularly when combined with LGE
(14). In the present study LGE-MRI was used to detect infarct
volume in vivo immediately prior to collection of the heart for
in vitro OPT. Analysis revealed a significant correlation be-
tween volumes calculated by the two different modalities,
although the actual volumes calculated by OPT tended to be
lower than those from MRI. There are several potential reasons
for this discrepancy. It has been suggested that LGE-MRI
overestimates infarct injury because of the kinetics of Gd
distribution and accumulation in areas of edema (7, 19). This
error may be magnified by dependence of the MRI volume
calculation on data from nine short-axis slices, rather than the
hundreds of slices collected by OPT. The limited resolution of
MRI relative to OPT also makes it less likely to identify viable
myocardial tissue within the infarct and as a result exclude it
from the infarct area. However, like histology, OPT may also
underestimate the extent of injury. Fixation and methanol
dehydration during tissue preparation have been associated
with tissue shrinkage (8). This could lead to underestimation of
relative infarct volume, or area in histological analysis, partic-
ularly if infarct and healthy tissue respond differently to tissue
processing.
A key component of any study aimed at investigation of
infarct healing is characterization of the processes involved,
including inflammatory cell recruitment and neovasculariza-
tion, both commonly detected in tissue sections by immuno-
histochemistry (9, 16). Experiments conducted here demon-
strate that tissue that has undergone processing for OPT retains
its integrity and immunoreactivity, permitting detection of
CD31 and Mac-2 for identification of endothelial cells and
macrophages respectively. OPT can facilitate this kind of
investigation by identifying the most appropriate area of the
infarct for tissue collection and analysis. In developmental
studies specific antibodies have been used to detect proteins of
interest and their distribution within the reconstructed embryo
(22). Within the heart antibody penetration is likely to be more
limited, but the potential exists for whole tissue staining of the
vascular endothelium that can be accessed during myocardial
perfusion and this merits further investigation.
As with other methods OPT has its limitations. Ironically,
while it is the strong autofluorescence of heart tissue that
enables OPT imaging to acquire such good quality images this
also limits detection of e.g., green or red fluorescent protein, or
of exogenous antibody-conjugated fluorescent probes. There
are various protocols to quench autofluorescence (1, 2), and it
may be possible to apply these to improve detection of specific
proteins. Tissue must also be optically cleared prior to scan-
ning, and although the lipophilic agent (benzyl benzoate/
benzyl alcohol) used for this purpose is reported to cause
minimal deformation of tissue morphology (4), it can remove
lipid pools from tissue. While this is an issue shared with
standard histology, where tissue preparation can also remove
lipid, it may limit the use of OPT for some applications. The
image quality achieved is superior to that of other 3D imaging
techniques, and even comparable to histological sections.
However, it could also be improved further, perhaps by refine-
ment of the back-projection algorithms used to reconstruct
OPT data sets (28, 29).
In conclusion, this study demonstrates that OPT imaging is
a nondestructive, accurate approach for routine assessment of
murine myocardial injury in 2D and 3D. The data generated
correlate well with conventional 2D histological approaches
but permit calculation of infarct volume that correlates with
volumes generated by MRI. Application of OPT may help to
reduce the number of animals required to detect differences in
infarct size in response to therapeutic intervention. While there
are some current limitations, OPT has the potential to be
applied beyond detection of tissue injury, for example in 3D
assessment of anatomical features such as cardiac valve steno-
sis. Developments in this area and in detection of fluorescent
proteins within the myocardium hold significant promise.
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